A significant proportion of malaria drugs sold in Kenya’s private sector are not approved by recommended global health organisations.
According to a new study published in the current issue of Malaria journal, more than 40 per cent of private sector outlets (mainly pharmacies, chemists and clinics) sell malaria treatment medicines — known as Artemisinin Combination Therapies (ACTs) — that lack approval from the World Health Organisation (WHO), the Global Fund or the European Medicines Agency (EMA) quality assurance programmes.
